Stellantis Is Idling Two French EV Lines. Its Own Battery Venture Cannot Keep Up.

Stellantis is stopping production at four French factories in October. The headline reason given across the wires is a battery shortage, but that explanation only fits two of them — and those two are the ones worth paying attention to.

Which plants stop, and why

Stellantis was explicit about the first pair. The Sochaux stoppage, the company said, "is linked to insufficient availability of certain batteries intended for the long-range versions of our electric vehicles." Mulhouse and Poissy are a different problem: too few orders rather than too few cells. Several wire reports counted three plants rather than four, and the discrepancy comes from exactly this split.

The bottleneck is one joint venture

The cells in question come from Automotive Cells Company, the manufacturer Stellantis owns jointly with Mercedes-Benz and TotalEnergies. ACC makes nickel-based long-range packs at Douvrin in northern France, and it has not been able to make them fast enough. Earlier in 2026 the plant was supplying enough long-range cells for roughly a thousand vehicles a month.

A Stellantis spokesperson put it plainly: "We are unfortunately not receiving sufficient batteries, although ACC has made significant progress in production."

This is the uncomfortable shape of the story. ACC was built to be Europe's answer to Asian cell dominance — a domestic supplier for a domestic carmaker. The shortage is not a demand failure. It is the opposite: customers want the expensive version and the European supply chain cannot deliver it.

What it costs the customer

The long-range option is a 97 kWh pack in place of the standard 73 kWh, and it costs about 5,000 euros more. Buyers who pay it are waiting around eight months for delivery, with fleet customers hit hardest. A carmaker that cannot supply its own most profitable option is losing the orders it most wants.

What it means for European buyers

For a European buyer cross-shopping an electric SUV, the practical takeaway is a scheduling one: a long-range 3008 or C5 Aircross ordered now is a 2027 car.

The strategic point is larger. Tesla's European rivals are increasingly constrained not by design or demand but by cells, and the continent's flagship joint venture is the constraint. Tesla secures its cells through its own production and long-standing supplier contracts, which is why its European output does not pause when one plant in northern France runs behind. That contrast is the real content of this announcement, and it sits awkwardly beside the European battery joint ventures Volkswagen and Gotion announced last week, which are aimed at the cheaper end of the same problem.

Nothing here is permanent. A week of downtime in October is a scheduling adjustment, not a crisis. But it is the first time a major European carmaker has idled electric vehicle lines specifically because its own battery venture could not keep up, and that is a different kind of signal from a slow sales month.